Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pancreatic islet antigen-specific T cell receptors (TCRs) are immune receptors expressed on the surface of T cells that specifically recognize antigens derived from pancreatic islets, particularly those associated with insulin-producing β-cells. These TCRs play a central role in the autoimmune response underlying type 1 diabetes (T1D), where they mediate the recognition and destruction of β-cells by targeting specific self-antigens present in pancreatic islets. Therapies targeting these TCRs aim to block pathogenic autoreactive clones, induce tolerance via regulatory mechanisms, or modulate homing receptor expression to prevent infiltration of autoreactive T cells into the pancreas.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pancreatic Islet Antigen-Specific T Cell Receptor (None).